Quantitative Imaging Tools for Lung Cancer Drug Assessment. Questo articolo non è disponibile.
Lingua: inglese
Editore: John Wiley and Sons Inc, US, 2008
- Rilegato
- Nuovo
Da: Rarewaves.com UK, London, Regno UnitoRarewaves.com UK
Venditore AbeBooks dal 11 giugno 2025
Condizione: Nuovo
EUR 179,47
Descrizione dell’articolo da parte del venditore
Presents chapters written by leading clinical researchers in the field of lung cancer, where high resolution 3-D imaging technology appears to hold the greatest near-term promise, as well as contributions from recognized experts in CAD, medical information technology systems, regulatory procedure, x-ray standards development, and clinical trial design. These expert contributors discuss the current state of the art and provide a road map for directing further research in lung cancer as well as other organ systems.
Codice articolo LU-9780470118801
- Titolo
- Quantitative Imaging Tools for Lung Cancer Drug Assessment
- Autore
- James L. Mulshine
- Editore
- John Wiley and Sons Inc, US
- Anno di pubblicazione
- 2008
- Condizione
- New
- Rilegatura
- Hardback
- Lingua
- inglese
- ISBN 10
- 0470118806
- ISBN 13
- 9780470118801
- Peso dell'articolo
- 426 grammi
- Dimensioni
- 16.26 x 1.65 x 24.13 cm
"Riassunto" può appartenere a un’altra edizione di questo titolo.
Informazioni sull’autore
James L. Mulshine, MD, is a Professor of Internal Medicine, Associate Provost of Research and Vice President, Rush University Medical Center in Chicago, Illinois.?In this position, Dr. Mulshine is the primary academic officer responsible for managing research activities at Rush University Medical School. He is an internationally recognized expert on lung cancer.?Over the last few years, Dr. Mulshine has been working with a range of organizations to accelerate the use of high resolution spiral CT in the quantitative evaluation of drug response for early lung cancer.
"Descrizione articolo" può appartenere a un’altra edizione di questo titolo.